Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors

Detalles Bibliográficos
Autores principales: Perez, Lia Elena, Fernandez, Hugo, Ayala, Ernesto, Beato, Francisca, Neuger, Anthony, Pidala, Joseph, Schell, Michael J., Anasetti, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382111/
https://www.ncbi.nlm.nih.gov/pubmed/27991896
http://dx.doi.org/10.1038/bmt.2016.330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382111/
https://www.ncbi.nlm.nih.gov/pubmed/27991896
http://dx.doi.org/10.1038/bmt.2016.330

Ejemplares similares